PATENT CLAIM ANALYSIS

Application Number: 16191693
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["435", "060000"]

Abstract:
The present invention relates to 1-aza-bicycloalkyl derivatives of formula I, wherein X is CH 2  or a single bond; Y is a group of formula and wherein R has the meanings as defined in the specification, which compounds are alpha 7 nicotinic acetylcholine receptor (nAChR) agonists; to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

Claim (Index 5):
The method of  claim 4 , wherein the neurodegenerative disorder is selected from the group consisting of: senile dementia, Alzheimer's disease, and an intellectual impairment disorder.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 98.0
- Lexical Diversity: 1.25455
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15398427', '14643275', '11823312', '12262896', '12638880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6533061675304378
- 35 USC 102 Novelty (BERT): 0.5257340338743253
- Combined Prediction Score: 0.6405489541648266
- Mean Citation Score: 265.025034
- Max Citation Score: 295.0835600000001
- Similarity Product: 141.06569648038158

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test